News and Announcements
Qove Capital Golf Heights Gosford Ltd Capital Raise Closing Tomorrow
- Published June 22, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Qove Capital Golf Heights Gosford Ltd is a residential development project in Gosford City, with fixed return of up to 30% over the life of the project. The fund is currently raising $3.2m in redeemable preference shares.
Qove Capital Golf Heights Gosford has already raised $1.5m (which is $1m over minimum subscription) and making a final call to potential investors to this investment opportunity that closes tomorrow the 23rd June 2016.
The transaction in summary:
- Gosford NSW 40 unit development
- Redeemable Preference Shares in Mez lending entity to project
- Ranking senior to developer equity
- 18 – 30% absolute fixed return (unfranked) at completion
- Estimated completion: 24 months
- Project cost: $15m+
- Minimum subscription reached
Project Status:
- Location: Gosford CBD Hospital Precinct
- DA 49560/2016 Approved by Central Coast Council 16 Feb 2017
- CC underway
- 35% units already sold
- Estimated construction start: Q3/Q4 2017
- Prospectus attached
To request an offer please click on the button below.
If you missed on seeing Qove Capital Golf Heights Gosford present live last night at the Sydney Fund Manager Investor Evening please listen to a recorded podcast from Qove Capital.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
